Research programme: ORL1 antagonists - Adolor
Alternative Names: ORL1 antagonists research programme - AdolorLatest Information Update: 07 Oct 2003
Price :
$50 *
At a glance
- Originator Adolor Corporation
- Class Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain; Pain
Most Recent Events
- 31 Dec 2002 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
- 31 Dec 2002 Discontinued - Preclinical for Pain in USA (unspecified route)
- 26 Apr 2002 Preclinical trials in Neuropathic pain in USA (unspecified route)